Company Spotlight

Haima Therapeutics is preparing to take SynthoPlate from the lab bench to human clinical trials. Built from Christa Pawlowski’s doctoral research at Case Western Reserve University, the synthetic platelets are designed to support the body’s natural clotting response. This feature explores the science, funding, military influence, and translational decisions behind Haima’s journey toward the clinic.

By Sirena Meade, The Biotech Beacon When people think about bringing a medical device to market, they often imagine a brilliant invention followed by a long wait for FDA clearance. In reality, FDA review is only one milestone along a much longer journey. Every successful medical device begins with a problem, not a product. From there, it moves through engineering, testing, regulatory planning, quality systems, manufacturing, commercialization, and finally into the hands of ph

In biotech, breakthroughs don’t begin as companies, they begin as questions. On a rainy day at Rising Star Coffee Roasters in Cleveland, over coffee and conversation, Elizabeth Berezovsky sat down and walked me through the question that ultimately became a company. For Elizabeth and her co-founders, the question centered on a fundamental biological problem. What if we could stop cells from dying when they’re not supposed to? It’s a deceptively simple idea, one that sits at t

In Cleveland’s Midtown innovation corridor, the renovated Baker Electric Building houses more than 20 local startups. Among them is a small analytical laboratory preparing for a launch years in the making. Cleveland Analytical was founded in 2023 with a mission to help the city of Cleveland address a persistent public health problem: lead contamination in older housing. The Baker Electric Building in Cleveland’s Midtown innovation corridor, home to Cleveland Analytical and a

Breakthrough science and major funding rounds tend to define the biotech industry. But the work that connects the two is often less visible yet just as vital. Somewhere between a promising idea in a lab and a venture-backed company, there’s a critical layer of work that often goes unseen. It’s where scientific ideas are pressure-tested, shaped, and translated into something that could actually become a business. It’s also where professionals like Lindsay Sulzer, Ph.D., foun